Linda Dowling
Rush University Medical Center
Internal medicineLogistic regressionEmergency medicineLung cancerMedicaidHarmLung cancer screeningLungSafety netResponse rate (survey)Tissue diagnosisUnnecessary ProcedurePrimary careUniversity medicalLung imagingComputed tomographyMedicine
2Publications
1H-index
5Citations
Publications 3
Newest
#1Chien-Ching Li (Rush University Medical Center)H-Index: 9
#2Alicia K. Matthews (UIC: University of Illinois at Chicago)H-Index: 34
Last. Linda Dowling (Rush University Medical Center)H-Index: 1
view all 0 authors...
Objective: The purpose of this study was to examine the influence of access to care on the uptake of low dose computed tomography (LDCT) lung cancer screening among a diverse sample of screening-eligible patients. Methods: We utilized a cross-sectional study design. Our sample included patients evaluated for lung cancer screening at a large academic medical center (AMC) between 2015 and 2017 who met 2013 USPSTF guidelines for LDCT screening eligibility. The completion of LDCT screening (yes, no)...
Source
#1Julia M. Coughlin (Rush University Medical Center)H-Index: 4
#2Yanyu Zang (Rush University Medical Center)H-Index: 1
Last. Christopher W. Seder (Rush University Medical Center)H-Index: 24
view all 13 authors...
Background Low-dose computed tomography (LDCT) scan for lung cancer screening is underutilized. Studies suggest that up to one-third of providers do not know the current lung cancer screening guidelines. Thus, identifying the barriers to utilization of LDCT scan is essential. Methods Primary care providers in three different healthcare settings in the United States were surveyed to assess provider knowledge of LDCT scan screening criteria, lung cancer screening practices, and barriers to the uti...
Source
#1Justin M. Karush (Rush University Medical Center)H-Index: 2
#2Andrew T. Arndt (Rush University Medical Center)H-Index: 3
Last. Michael J. Liptay (Rush University Medical Center)H-Index: 33
view all 9 authors...
Background Concern over high false-positive rates and the potential for unintended harm to patients is a critical component of the lack of widespread adoption of lung cancer screening.
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.